1999 to 2018 Saw Increase in Number of Metabolically Healthy Adults With Obesity
FRIDAY, March 10, 2023 (HealthDay News) — The prevalence of metabolically healthy obesity (MHO) among U.S. adults increased significantly in the past two decades, according to a study published online March 9 in JAMA Network Open.Jiang-Shui Wang, M.B…
Learn MoreDiabetic Retinopathy Incidence, Progression May Be Lower in Native Americans
FRIDAY, March 10, 2023 (HealthDay News) — Estimates of diabetic retinopathy (DR) incidence and progression may be lower than those previously reported for American Indian and Alaska Native individuals, according to a study published online March 9 in…
Learn MoreDiabetes Rates Keep Rising Among Young Americans
THURSDAY, March 9, 2023 (HealthDay News) — Troubling new research finds that rates of type 1 and type 2 diabetes are continuing to increase in children and young adults.Asian or Pacific Islander, Black and Hispanic children had higher rates, the stud…
Learn MorePreconception Diabetes, Prediabetes Increase Risk for Preterm Birth
WEDNESDAY, March 8, 2023 (HealthDay News) — Preconception diabetes or prediabetes is associated with a higher risk for preterm birth, according to a study published online Feb. 16 in the Journal of Women’s Health.Erin Delker, Ph.D., M.P.H., from the …
Learn MoreVerapamil Partially Preserves C-Peptide Secretion in Children With T1DM
TUESDAY, March 7, 2023 (HealthDay News) — Verapamil partially preserves stimulated C-peptide secretion at 52 weeks after diagnosis among children with newly diagnosed type 1 diabetes, according to a study published online Feb. 24 in the Journal of th…
Learn MoreEli Lilly reducirá los precios de la insulina, y limitará los costos mensuales de desembolso a 35 dólares
MIÉRCOLES, 1 de marzo de 2023 (HealthDay News) — Pronto, más estadounidenses pagarán menos por la insulina.Eli Lilly, uno de los tres fabricantes de insulina, planifica reducir sus precios de lista del medicamento en un 70 por ciento, y limitar los c…
Learn MoreClinically Relevant Benefits Seen for GLP-1RA, SGLTi Treatment of T1DM
THURSDAY, March 2, 2023 (HealthDay News) — Glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) are beneficial for treating type 1 diabetes mellitus (T1DM), with similar reductions in glycated h…
Learn MoreEli Lilly to Slash Insulin Prices, Cap Monthly Out-of-Pocket Costs at $35
WEDNESDAY, March 1, 2023 (HealthDay News) — More Americans will soon be paying less for their insulin. Eli Lilly, one of the three insulin manufacturers, plans to cut its list prices of the drug by 70 percent and cap out-of-pocket costs at $35 a mont…
Learn MoreSpinal Cord Stimulation May Ease Diabetic Neuropathy
WEDNESDAY, March 1, 2023 (HealthDay News) — Electrical stimulation from a spinal cord implant can provide long-lasting relief for people with diabetic neuropathy, updated clinical trial results show.“Two years after starting with using that stimulato…
Learn MoreAAN: Spinal Cord Stimulation Beneficial for Diabetic Neuropathy
WEDNESDAY, March 1, 2023 (HealthDay News) — Spinal cord stimulation (SCS) provides pain relief and neurological improvement for patients with painful diabetic neuropathy (PDN), according to a study scheduled for presentation at the upcoming annual me…
Learn More